$NGNE Income Statement | Understand Stock

$NGNE

$26.99 +$3.45 (14.66%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue under licensing agreements
Operating expenses:
Research and development
Research and development expenses
General and administrative expenses
Gain on sale of Aquinox Canada
Total operating expenses

Loss from operations
Interest income
Other income (loss), net
Other income (expense):
Interest income
Fair value allocated to bargain purchase gain
Interest expense
Other income
Other expense
Net loss
Class A Common Stock
Class B Common Stock
Total net loss

Unrealized loss on available-for-sale securities
Comprehensive loss
Per share information
Net loss per share, basic (in dollars per share)
Class A Common Stock
Class B Common Stock
Total net loss per share, basic (in dollars per share)

Net loss per share, diluted (in dollars per share)
Class A Common Stock
Class B Common Stock
Total net loss per share, diluted (in dollars per share)

Weighted-average shares of common stock outstanding, basic (in shares)
Class A Common Stock
Class B Common Stock
Total weighted-average shares of common stock outstanding, basic (in shares)

Weighted-average shares of common stock outstanding, diluted (in shares)
Class A Common Stock
Class B Common Stock
Total weighted-average shares of common stock outstanding, diluted (in shares)

Comments